Article

Cysteine dependence in Lactobacillus iners constitutes a novel therapeutic target to…

medRxiv · 2021 · Bloom, S. M.; Mafunda, N. A.; Woolston, B. M.; Hayward, M. R.; Frempong, J. F.; Abai, A. B.; Xu, J.; Mitchell, A. J.; Westergaard, X.; Hussain, F. A.; Xulu, N.; Dong, M.; Dong, K. L.; Gumbi, T.; Ceasar, X.; Rice, J. K.; Choksi, N.; Ismail, N.; Ndung'u, T.; Ghebremichael, M. S.; Balskus, E. P.; Mitchell, C. M.; Kwon, D. S.

Key facts

Title Cysteine dependence in Lactobacillus iners constitutes a novel therapeutic target to modify the vaginal microbiota
First author Bloom, S. M.; Mafunda, N. A.; Woolston, B. M.; Hayward, M. R.; Frempong, J. F.; Abai, A. B.; Xu, J.; Mitchell, A. J.; Westergaard, X.; Hussain, F. A.; Xulu, N.; Dong, M.; Dong, K. L.; Gumbi, T.; Ceasar, X.; Rice, J. K.; Choksi, N.; Ismail, N.; Ndung'u, T.; Ghebremichael, M. S.; Balskus, E. P.; Mitchell, C. M.; Kwon, D. S.
Journal medRxiv
Published Jun 12, 2021
DOI 10.1101/2021.06.12.448098
Devices mentioned K000203, K000509, K781602, K781603, K781604, K800781, K841139, K841143, K844382, K844383, K964560, K981990
Product codes mentioned EFB, JSG, JSJ, JSO, JTN, JTO, KIS, JJH, JSC, JSD, JSH, JSI and 3 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature